Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.

Frank, Samuel; Anderson, Karen E; Fernandez, Hubert H; Hauser, Robert A; Claassen, Daniel O; Stamler, David; Factor, Stewart A; Jimenez-Shahed, Joohi; Barkay, Hadas; Wilhelm, Amanda; Alexander, Jessica K; Chaijale, Nayla; Barash, Steve; Savola, Juha-Matti; Gordon, Mark Forrest; Chen, Maria.

Afiliação

Frank S; Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA, 02215, USA. sfrank2@bidmc.harvard.edu.
Anderson KE; Georgetown University, Washington, DC, USA.
Fernandez HH; Cleveland Clinic, Cleveland, OH, USA.
Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL, USA.
Claassen DO; Vanderbilt University Medical Center, Nashville, TN, USA.
Stamler D; Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA, USA.
Factor SA; Emory University, Atlanta, GA, USA.
Jimenez-Shahed J; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Barkay H; Teva Pharmaceutical Industries Ltd., Netanya, Israel.
Wilhelm A; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Alexander JK; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Chaijale N; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Barash S; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Savola JM; Teva Pharmaceuticals International GmbH, Basel, Switzerland.
Gordon MF; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Chen M; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.

Neurol Ther ; 2024 Sep 12.

Article em En | MEDLINE | ID: mdl-39266813

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article